Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials

Documenti analoghi

• Body Mass Index and All‐Cause, Cancer, and Cardiovascular Mortality in Adults Aged 16–50 Years With and Without Type 2 Diabetes: An Analysis of Primary Care Records in England
  di: Yijing Chen, et al.
  Pubblicazione: (2026)
• Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents
  di: Setor K. Kunutsor, et al.
  Pubblicazione: (2024)
• Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta‐analysis of trials investigating intensive glucose‐lowering strategies in people with type 2 diabetes
  di: Setor K. Kunutsor, et al.
  Pubblicazione: (2024)
• Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study
  di: Testimony Ipaye, et al.
  Pubblicazione: (2025)
• Sodium‐glucose co‐transporter 2 inhibitors and obesity‐associated cancers in people with type 2 diabetes: A real‐world observational study
  di: Testimony Ipaye, et al.
  Pubblicazione: (2026)